{"nctId":"NCT03691649","briefTitle":"A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study","startDateStruct":{"date":"2018-09-14","type":"ACTUAL"},"conditions":["Glaucoma and Ocular Hypertension"],"count":426,"armGroups":[{"label":"DE-117 Ophthalmic Solution","type":"EXPERIMENTAL","interventionNames":["Drug: DE-117 Ophthalmic Solution"]},{"label":"Timolol Maleate Ophthalmic Solution 0.5%","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Timolol Maleate Ophthalmic Solution 0.5%"]}],"interventions":[{"name":"DE-117 Ophthalmic Solution","otherNames":[]},{"name":"Timolol Maleate Ophthalmic Solution 0.5%","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nâ€¢ glaucoma or ocular hypertension\n\nExclusion Criteria:\n\n* Females who are pregnant, nursing, or planning a pregnancy\n* Any corneal abnormality or other condition interfering with or preventing reliable tonometric measurements","healthyVolunteers":false,"sex":"ALL","minimumAge":"12 Months","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Intraocular Pressure at Week 1","description":"Intraocular Pressure (IOP), the fluid pressure inside the eye was measured with calibrated Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time points throughout the day. Analysis using Mixed-Effects Model for Repeated Measures (MMRM)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.0","spread":"0.22"},{"groupId":"OG001","value":"19.1","spread":"0.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.0","spread":"0.21"},{"groupId":"OG001","value":"18.2","spread":"0.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.5","spread":"0.21"},{"groupId":"OG001","value":"17.9","spread":"0.21"}]}]}]},{"type":"PRIMARY","title":"Intraocular Pressure at Week 6","description":"Intraocular Pressure (IOP), the fluid pressure inside the eye was measured with calibrated Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time points throughout the day. Analysis using Mixed-Effects Model for Repeated Measures (MMRM)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.8","spread":"0.20"},{"groupId":"OG001","value":"18.4","spread":"0.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.9","spread":"0.20"},{"groupId":"OG001","value":"18.0","spread":"0.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.5","spread":"0.21"},{"groupId":"OG001","value":"17.7","spread":"0.21"}]}]}]},{"type":"PRIMARY","title":"Intraocular Pressure at Month 3","description":"Intraocular Pressure (IOP), the fluid pressure inside the eye was measured with calibrated Goldmann applanation tonometer in millimeters mercury (mmHg) at 3 time points throughout the day. Analysis using Mixed-Effects Model for Repeated Measures (MMRM)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.7","spread":"0.24"},{"groupId":"OG001","value":"18.5","spread":"0.24"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.8","spread":"0.21"},{"groupId":"OG001","value":"17.7","spread":"0.21"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.6","spread":"0.22"},{"groupId":"OG001","value":"17.8","spread":"0.21"}]}]}]},{"type":"SECONDARY","title":"Mean Diurnal Intraocular Pressure (IOP) at Month 3 (First Key Secondary Endpoint)","description":"Mean Diurnal Intraocular Pressure (IOP) at Month 3: Analysis using Mixed-Effects Model for Repeated Measures (MMRM) on observed cases.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.0","spread":"0.20"},{"groupId":"OG001","value":"18.0","spread":"0.19"}]}]}]},{"type":"SECONDARY","title":"Intraocular Pressure (IOP) at Week 1 With Baseline Mean Diurnal IOP Less Than 25 mmHg (Second Key Secondary Endpoint)","description":"Intraocular Pressure (IOP) at Week 1 with baseline mean diurnal IOP less than 25 mmHg (Second Key Secondary Endpoint)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.9","spread":"0.25"},{"groupId":"OG001","value":"18.2","spread":"0.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.2","spread":"0.24"},{"groupId":"OG001","value":"17.3","spread":"0.24"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.8","spread":"0.25"},{"groupId":"OG001","value":"17.2","spread":"0.25"}]}]}]},{"type":"SECONDARY","title":"Intraocular Pressure (IOP) at Week 6 With Baseline Mean Diurnal IOP Less Than 25 mmHg (Second Key Secondary Endpoint)","description":"Intraocular Pressure (IOP) at Week 6 with baseline mean diurnal IOP less than 25 mmHg (Second Key Secondary Endpoint)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.7","spread":"0.24"},{"groupId":"OG001","value":"17.8","spread":"0.24"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.0","spread":"0.25"},{"groupId":"OG001","value":"17.4","spread":"0.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.6","spread":"0.23"},{"groupId":"OG001","value":"17.1","spread":"0.23"}]}]}]},{"type":"SECONDARY","title":"Intraocular Pressure (IOP) at Month 3 With Baseline Mean Diurnal IOP Less Than 25 mmHg (Second Key Secondary Endpoint)","description":"Intraocular Pressure (IOP) at Month 3 with baseline mean diurnal IOP less than 25 mmHg (Second Key Secondary Endpoint)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.6","spread":"0.29"},{"groupId":"OG001","value":"17.7","spread":"0.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.8","spread":"0.25"},{"groupId":"OG001","value":"16.9","spread":"0.25"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.7","spread":"0.25"},{"groupId":"OG001","value":"17.2","spread":"0.25"}]}]}]},{"type":"SECONDARY","title":"Mean Diurnal Intraocular Pressure (IOP) at Week 1 (Third Key Secondary Endpoint)","description":"Mean Diurnal Intraocular Pressure (IOP) at Week 1: Analysis using Mixed-Effects Model for Repeated Measures (MMRM) on observed cases.\n\nMean Diurnal IOP at week 1 is defined as the average IOP of all three timepoints (8AM, 10AM and 4PM) at week 1.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.1","spread":"0.19"},{"groupId":"OG001","value":"18.4","spread":"0.19"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":4,"n":211},"commonTop":["Conjunctival hyperaemia","Vision blurred","Vital dye staining cornea present","Instillation site pain","Photophobia"]}}}